Notice of Application to Register Trade Name Products (Notice No. MPI ACVM 108)
Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register trade name products under section 9(1) of the Act:
Trade Name: Lenivia 0.5mg; Lenivia 1.0mg; Lenivia 1.5mg; Lenivia 2.0mg; Lenivia 3.0mg
Registration Number: A012247; A012248; A012249; A012250; A012251
Active Ingredient and Concentrations:
Izenivetmab 0.5, 1.0, 1.5, 2.0 or 3.0mg/mL
Formulation Type: Aqueous solution
Application method/administration route: The recommended dose is 0.05–0.1 mg/kg bodyweight, once every three months. For subcutaneous use.
Use Claim:
For the alleviation of pain associated with osteoarthritis in dogs.
Other Information:
Izenivetmab is a caninised monoclonal antibody targeting caning nerve growth factor (NGF) expressed through recombinant techniques in Chinese hamster ovary (CHO) cells.
Any person may make a written submission to the Director-General concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.
The following address is:
ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.
MPI encourages submission by email.
The applicant’s address for service is:
Zoetis New Zealand Limited, Level 4, 8 Mahuhu Crescent, Auckland Central, Auckland 1010. Postal Address: PO Box 2094, Shortland Street, Auckland 1140.
Dated at Wellington this 22nd day of December 2025.
SHALEEN NARAYAN, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).